ERYTECH Pharma S.A.

NASDAQ: ERYP · Real-Time Price · USD
0.78
0.01 (1.30%)
At close: Jun 28, 2023, 9:48 PM

ERYTECH Pharma S.A. Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a
Cost of Revenue
n/a n/a
Gross Profit
n/a n/a
Operating Income
-2.8M -56.52M
Interest Income
4.45M 13K
Pretax Income
293K -53.8M
Net Income
-228K -53.8M
Selling & General & Admin
13.89M 15.1M
Research & Development
19.91M 45.1M
Other Expenses
-6.65M -3.69M
Operating Expenses
27.15M 56.52M
Interest Expense
1.36M 2.14M
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
27.15M 56.52M
Income Tax Expense
521K 2K
Shares Outstanding (Basic)
31.02M 23.69M
Shares Outstanding (Diluted)
31.02M 23.69M
EPS (Basic)
-0.01 -2.27
EPS (Diluted)
-0.01 -2.27
EBITDA
-22.69M -47.45M
EBIT
1.66M -51.66M
Depreciation & Amortization
-19.9M 5.38M